Eli Lilly’s 340B Ultimatum Forecasts A New Drugmaker-Hospital Battle

Eli Lilly’s 340B Ultimatum Forecasts A New Drugmaker-Hospital Battle The company announced a new policy in which it plans to withhold 340B drug savings from hospitals if they do not disclose pharmacy claims data, Modern Healthcare reports, escalating existing fights between drug manufacturers and providers over the 340B Drug Pricing Program. https://kffhealthnews.org/morning-breakout/health-industry-060426/